Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Looking to earn more? Discover simple ways to integrate money-making activities into your daily routine.
27,728 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
Solana is seeing record ETF inflows and booming on-chain activity, yet the token price remains muted. Analysts say th...
As July 29 approaches, investors ask if they should microsoft stock before the earnings release. This guide breaks do...
This piece examines which stocks people actually search for and why those trends matter. Learn how to separate curios...
Navigate Greenlight Re’s GLRE earnings call with a clear eye on underwriting results, investment income, and capital ...
Horizon (HRZN) investors want clarity on Q3 2025 results and what comes next. This article breaks down horizon (hrzn)...
AMD posts a sharp rise in free cash flow as data center demand surges, while Intel bankrolls a costly foundry rebuild...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
A high-profile nod from a tech legend can spark instant moves in AI chip stocks. This guide explains how to separate ...
Two budding EV stars, Lucid and Rivian, are racing from zero to scale. This deep dive compares their paths, risks, an...
As Netflix prepares to report earnings after the bell, investors are dialed in on one question that could shape the s...